Similar Items: JAK Activation Drives MED15-Associated Melanocyte Dysfunction in Vitiligo Beyond Immune Cells
- Consensus-based guidelines for surgical management of vitiligo, by Vitiligo Task Force, IADVL Academy 2024- 2025
- Analyzing the Differential Expression of Vitiligo Genes by Bioinformatics Methods
- JAK Inhibitors for Treatment of VEXAS Syndrome: A Systematic Review of 186 Cases
- Public Interest in Janus Kinase (JAK) Inhibitors for Alopecia Areata: A Google Trend Analysis
- Genetic Evidence Linking Immune Cell Subsets to Psoriatic Arthritis Susceptibility: A Mendelian Randomization Study
- Demographic and Socioeconomic Factors Associated With ART Nonadherence Among 15 Years and Older South Africans. Evidence From the 2022 Cross-Sectional Population-Based Household Survey